Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 40.75
-1.00 (-2.40%)
Apr 20, 2026, 1:24 PM CST
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.65 billion as of April 20, 2026. Its market cap has decreased by -10.61% in one year.
Market Cap
3.65B
Enterprise Value
2.88B
Revenue
811.56M
Ranking
n/a
PE Ratio
13.86
Stock Price
40.75
Market Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has increased from 3.53B to 3.65B, an increase of 3.67%. That is a compound annual growth rate of 0.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.74B | -2.45% |
| Dec 31, 2025 | 3.84B | -12.06% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Optical Technology | 5.95B |
| Pacific Hospital Supply | 5.88B |
| St.Shine Optical | 5.47B |
| SciVision Biotech | 4.74B |
| Bionime | 4.51B |
| Nang Kuang Pharmaceutical | 3.59B |
| ICARES Medicus | 3.37B |
| BenQ Medical Technology | 1.83B |